Genevant Sciences to Collaborate with Novo Nordisk to Develop Gene Editing Treatment for Hemophilia A
Genevant Sciences LNP Technology Used in samRNA Covid-19 Vaccine Candidate Behind Gritstone bio’s BARDA Award
Gritstone bio and Genevant Sciences Announce Option and License Agreement
Korro Bio and Genevant Sciences Enter into Collaboration Agreement to Develop RNA Editing Therapeutic for Alpha-1 Antitrypsin Deficiency
Genevant Sciences and Arbutus Biopharma File Patent Infringement Lawsuit Against Moderna
Genevant Sciences Announces Global Collaboration and License Agreement with Takeda to Develop Novel Nonviral Gene Therapies for Up to Two Rare Liver Diseases
Genevant Sciences Announces Global Collaboration and License Agreement with Takeda to Develop Novel Nucleic Acid Therapeutics for Liver Fibrosis
Gritstone and Genevant Sciences Announce License Agreement for COVID-19 Vaccine
Sarepta Therapeutics and Genevant Sciences to Collaborate for LNP-Based Gene Editing Therapeutics
Contact us
We are always ready to connect with people interested in the pioneering work we do.